Evaluation of the Anticonvulsant and Antidepressant Effects of the Aqueous Extract of the Leaves of Ascotheca paucinervia (T. Anderson ex C.B. Clarke) Heine in Mice

Bassoueka D’Avila Judicaël *

Laboratory of Pharmacodynamics and Experimental Physiopathology (L2PE), Faculty of Sciences and Technology, Marien Ngouabi University, BP: 69, Brazzaville, Congo.

Ondele Radar

Laboratory of Pharmacodynamics and Experimental Physiopathology (L2PE), Faculty of Sciences and Technology, Marien Ngouabi University, BP: 69, Brazzaville, Congo.

Omeka Ngassaki Gelvid

Laboratory of Pharmacodynamics and Experimental Physiopathology (L2PE), Faculty of Sciences and Technology, Marien Ngouabi University, BP: 69, Brazzaville, Congo.

Abena Ange Antoine

Biochemistry and Pharmacology Laboratory, Faculty of Health Sciences, Marien Ngouabi University, BP: 69, Brazzaville, Congo.

*Author to whom correspondence should be addressed.


Abstract

The present study was undertaken to evaluate the anticonvulsant and antidepressant effects of Ascotheca paucinervia leaves on mice by using strychnine at 2.5mg/kg to induce convulsions and the forced swimming test to create a stressful situation, respectively. Concerning convulsions, only the 500mg/kg extract significantly increases (p<0.001) the time to onset of convulsions and it non-significantly reduces the duration of convulsions induced by strychnine. In addition, the extract reduces very significantly in a dose-dependent manner the time of immobility and it significantly increases the swimming time as well as the climbing time at both doses. At the same time, the estimation of the acute toxicity of the extract from the leaves of Ascotheca paucinervia according to guideline No. 425 of the OECD (2022) shows that the latter is weakly toxic and its LD50 is greater than 5000mg/kg. In addition, the evaluation of the sedative effect of this extract shows that it produces a dose-dependent sedative effects and at doses of 250m/kg and 500mg/kg, the extract significantly potentiates the sleep induced by phenobarbital. In summary, the results obtained suggest that Ascotheca paucineervia leaves extract possesses anticonvulsant and antidepressant effects.

Keywords: Anticonvulsant activity, antidepressant activity, epilepsy, Ascotheca paucinervia


How to Cite

Judicaël, B. D., Radar, O., Gelvid, O. N., & Antoine, A. A. (2023). Evaluation of the Anticonvulsant and Antidepressant Effects of the Aqueous Extract of the Leaves of Ascotheca paucinervia (T. Anderson ex C.B. Clarke) Heine in Mice. European Journal of Medicinal Plants, 34(1), 1–11. https://doi.org/10.9734/ejmp/2023/v34i11115

Downloads

Download data is not yet available.

References

VIDAL. Vidal.

Accesson 2021

Available:www.vidal.fr>epilepsy>symptoms>: www.vidal.fr

Jost J. The determinants of the therapeutic deficit of epilepsy: Place of the quality of antiepileptics in sub-Saharan Africa, doctoral thesis, University of Limoges: Tropical Neuroepidemiology. 2018;306.

WHO Action against epilepsy: A public health imperative, Geneva, CCBY-NC-SA3.0IGO; 2019.

Rasekhi TR, Kathryn ND, Joely AM, Nei M, Sprling MR, Asma B, Donmez M. Improving the prediction of sudden unexpected death in epilepsy: SUDEP-7 to SUDEP-3, epilepsia, 2021;62: 1536-1545.

Guekht A, Brodie M, Secco M, Li S, Volkers N, Wiebe. The road to World Health Organization global action plan on epilepsy and neurological disorders, Epilepsia. flight. 2021; 62(5):1057-1063.

WHO. Main landmarks of epilepsy, World Health Organization. 2018.

Hingray C Biraben A psychiatric comorbidities and epilepsy, European psychiatry. 2015;30(8):S76.

Kougan Nkwokap GB. Isolation and characterization of saponosides from three plants of the Araliaceae and Dracaenaceae families and evaluation of their cytotoxic activities on tumor cells, Co-supervised thesis for obtaining the degree of Doctor of the University, University of Burgundy. 2010;184.

Bachman S. State of the World's Plants Report, Royal Botanic Gardens, Kew. 2016;7184

VIDAL. 2012 What are the origins of phytotherapy?

Available:www.vidal.fr>origins-phytotherapie

Accesson August 2022).

Dobillard A, Chaletain C. Synonymous and bibliographic index of plants from North Africa. 2013;1-5.

OECD (2022) Test No. 425: Acute Oral Toxicity: Dose Adjustment Method, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris.

Bassoueka DJ, Loufoua BAE, Etou-Ossibi AW, Nsondé-Ntandou, Ondelé R, ElionItou RDG, Ouamba JM, Abena AA. Anticonvulsant plants from the Congo, ethnobotanical approach, Phytotherapy. 2015;13:298-305.

Porsolt RD, Le Pichon M, Jalfre M. Depression: A new animal model sensitive to antidepressant treatments. Nature. 1977;266:730-732.

Chen L, Faas GC, Ferando I, Mody I. Novel insights into the behavioral analysis of mice subjected to the forced-swim test. Translational Psychiatry. 2015;5:1-9.

Gong Y, Han T, Chen W, Dib HH, Yang G, Zhuang R, Chen Y, Tong X, Xiaoxy Yet al. Prevalence of anxiety and depression symptoms and related risk factors among physicians in China: A Cross-Sectional study. PLOS. 2014;1:32-42.

Dhenain Marc. Primate models and therapeutic innovations against diseases of the central nervous system. 2020; 34-37.

Nkundineza JC, Nsonde Ntandou GF, Bassoueka D'AJ, Boumba LS, Makambila MC, Abena AA. Anticonvulsant and Sedative Effects of Cassia alata (Fabaceae) in Mice. Galore International Journal of Health Sciences and Research. 2020;5(1):28-37.

Reus-García MM, Sánchez-Campusano R, Ledderose J, Dogbevia GK, Treviño M, Hasan MT, Gruart A, Delgado-García JM. The claustrum is involved in cognitive processes related to the classical conditioning of eyelid responses in behaving rabbits. Cereb Cortex. 2021;31(1):281-300.

CATALA A. characterization and training methods of assistance dogs to help people with epilepsy, doctoral thesis, University of Biology Bretagne Santé Loire, Rennes. 2019;1:235.

Ken Ho. Steroid medicine reduces functions of calprie-burning brown fat, EDO; 2016.

Cryan JF, Leonard BE. Depression: From Psychopathology to Pharmacotherapy. Switzerland: Karger. 2010;207-208.

Seibert JB, Viegas JS, Almeida TC, Amparo TR, Rodrigues IV, Lanza JS, Frézard FJ, Soares RD, Teixeira LF, de Souza GH, Vieira PM. Nanostructured systems improve the antimicrobial potential of the essential oil from Cymbopogon densiflorus leaves. Journal of Natural Products. 2019;82(12):3208-20.

Ahangar N, Mirfetros S, Ebrahimzadeh MA. Antidepressant activity of polyphenol fraction of Artimisia absinthium L. Pharmacologyonline, 2011;1:825-832.

Pocket Atlas of Anatomy, The Nervous System The Sense Organs, 5th Edition, La Voixier Medicine; 2015.

Begum A, Hossen A, Moly A, Bhuiyan M., and Shahed-Al-Mahmud, M. In Vivo Sedative and Anxiolytic Activities of Thunbergia erecta (Acanthaceae) Leaves Activate Gamma-Aminobutyric Acid (GABA) Mediated Hyperpolarization in Swiss albino mice. Pharmacology and Pharmacy, 2019;10:177-193

Brain Facts. The Neuron ; 2012.

Catala A. characterization and training methods of assistance dogs to help people with epilepsy, doctoral thesis, University of Biology Bretagne Santé Loire, Rennes. 2019;1:235.

Graziella Cara. Discovery of a new mode of communication of the cells of our brain, presse.inserm.fr; 2021.

Hritcu L, Ionita R, Postu PA, Gupta GK, Turkez H, Lima TC. Anthocyanin on depression mice by increasing monoamine Neurotransmitter and up-regulating BDNF expression. J Function. 2017;1-18.

IBE. Annual report, 2019;26

Kurada L, Bayat A, Joshi S, Chahine A, Koubeissi MZ. Antiepileptic effects of electrical stimulation of the piriform cortex. Exp Neurol. 2020;325.

Labrakakis C, Rudolph U, De Koninck. The heterogeneity in GABAA receptor-mediated IPSC Kinetics reflects heterogeneity of subunit composition among inhibition and excitatory interneurons in spenal lamina II. Frontiers in cellular Neuroscience. 2014;8(424):1-12.

Michel N, Malvyne RD. the enteric nervous system and the digestive neuro-glio-epithelial unit, Bulletin of the French Veterinary Academy. 2013;166(1):7-12.

Olie JP. Psychotropic treatments. In: Guelfi JD, Rouillon F. Manuel de psychiatrie. 2nd edition. Paris: Elsevier Masson. 2012;571-574.

Palazzolo J. Depression. In: Depression and anxiety: Understanding them better to better manage them. Paris: Elsevier Masson. 2007;5-60.

Pfieger FW and Reber M. New insight into the mechanisms of neuron-glia communication, Med Sci (Paris). 2013;29(2):142-1444

Rahman MM, Ichiyanagi T, Komiyama T, Sato S, Konishi T, 2020, Antidepressant flavonoids and their relationship with

Stahl SM. Mood disorders. In: Essential psychopharmacology: Neuroscientific bases and practical applications. 2nd edition. Paris: Lavoisier. 2010;453-510.

Sundaram R, Gowtham L, Nayak.BS. The role of excitatory neurotransmitter glutamate in brain physiology and pathology, Asian Journal of Pharmaceutical and Clinical Research. 2012;5(2):1-7

Tchaleu Nguenkam BC, and Raharivelo A. Epidemiological profile of epilepsy in Central Africa and Madagascar, Medicine of Black Africa, August/September; 2011.

Tricoire L, Hepp R, Lambolez B. The delta family of glutamate receptors, Med Sci (Paris). 2018;34:662-664.

Yadav R, Subhash CG, Brandron GH, Bhatt JM, Stairs DJ, Shashank MD. Deletion of Glutamate Delta-1 Receptor in Mouse Leads to Aberrant Emotional and Social Behaviors, PloS ONE. 2012;7(3): e32969:1-13

Yuzaki M. Two Classes of secreted synaptic organizers in the central nervous system. Ann. Rev. Physiol. 2018;80:243-262.